PCR23 Methodological Considerations Related to Patient-Reported Outcomes Data (PRO) within HTA Appraisals Reviewed By Institut Für Qualität Und Wirtschaftlichkeit Im Gesundheitswesen (IQWIG) – Example of Triple-Negative Breast Cancer
Abstract
Authors
J. Antonova